theblood

Berlin, Germany Founded: 2022 • Age: 4 yrs
Menstrual blood testing kits are manufactured for health diagnostics.
Annual revenue - Latest available
Total funding $1.1M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 1 Services tracked
Competitors - Brand Intelligence

About theblood

theblood is a company based in Berlin (Germany) founded in 2022 by Isabelle Guenou, Miriam Santer, and Lucas Mittelmeier. It operates as a HealthTech. theblood has raised $1.07 million across 1 funding round from investors including RoX Health and Leanox. theblood offers products and services including Menstrual Blood Test.

  • Headquarter Berlin, Germany
  • Founders Isabelle Guenou, Miriam Santer, Lucas Mittelmeier
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Theblood Gmbh
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.07 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1.07 M (USD), Seed

    Mar 14, 2023

  • Investors
    RoX Health

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of theblood

theblood offers a comprehensive portfolio of products and services, including Menstrual Blood Test.

Product name locked
Category locked
Primary

Menstrual blood is analyzed for health insights.

Funding Insights of theblood

theblood has successfully raised a total of $1.07M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.07 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in theblood

theblood has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include RoX Health and Leanox.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Empowers early-stage digital health startups through expertise, networks, and industry insights.
Locked Locked Locked
Premium access

Investor details for theblood

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by theblood

Investments
Premium access

Investment portfolio details for theblood

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - theblood

Premium access

Detailed financials for theblood

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Theblood Comparisons

theblood Primary company
Description
Menstrual blood testing kits are manufactured for health dia...
Location
Berlin, Germany
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for theblood

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of theblood

Premium access

Detailed competitors of theblood

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Theblood

Premium access

Complete news archive for theblood

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about theblood

theblood was founded in 2022 and raised its 1st funding round 1 year after it was founded.

theblood is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.

Isabelle Guenou is the current CEO of theblood. They have also founded this company.

theblood is a funded company, having raised a total of $1.07M across 1 funding round to date.

Menstrual blood testing is offered by theblood to provide insights into womens health. Focus is placed on fertility, early menopause, hormonal imbalances, pain, and skin issues like acne. A non-invasive alternative to traditional blood tests is delivered, enabling regular tracking of health biomarkers. Solutions are developed to address the gender data gap in healthcare, ensuring timely diagnoses and informed health decisions for women.

theblood offers Menstrual Blood Test.

theblood has 2 investors. Key investors include RoX Health, and Leanox.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available